Composition
- Active ingredients
- OXALIPLATIN 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- OXALIPLATIN 100MG/20ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA021759-002 · Discontinued
- OXALIPLATIN 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA021759-003 · Discontinued
- OXALIPLATIN 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA021759-001 · Discontinued
- OXALIPLATIN 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- OXALIPLATIN 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA021492-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021492.
At a glance
- Brand name
- Eloxatin
- Active substance
- oxaliplatin
- Route
- Intravenous
- Dosage form
- Injectable
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 9 Aug 2002
- Application
- NDA021492-001